Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
fda
5
×
life sciences
national blog main
national top stories
new york blog main
5
×
new york top stories
biotech
boston blog main
clinical trials
new york
novartis
alnylam pharmaceuticals
boston top stories
johnson & johnson
san francisco blog main
san francisco top stories
sanofi
startups
wisconsin blog main
wisconsin top stories
abbvie
achromatopsia
akouos
alex gorsky
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
ashley mcevoy
astrazeneca
auris health
beta-thalassemia
bill cassidy
biogen
bluebird bio
bluerock therapeutics
boulder/denver blog main
What
deal
5
×
biggest
billion
cash
johnson
medical
medicines
plans
startup
years
acquire
acquiring
acquisitions
age
agreed
announced
appear
auris
bigger
bio
brings
builds
buy
ceo
cholesterol
collabs
come
companies
company
company’s
compound
covid
daniel
deerfield
developer
didn't
drug
emerging
end
eyeing
Language
unset
Current search:
deal
×
fda
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield